Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
9342-8530 Quebec Inc
DGCRF
Healthcare
Biotechnology
Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:DGCRF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
oceanblvd
X
View Profile
View Bullboard History
Post by
oceanblvd
on Jun 02, 2015 11:17am
national bank
perhaps a great technical sign is that national bank brokers sold stock down here maybe even a greater error than being buyers at $4 to $6 back when.
(0)
•••
Timorron
X
View Profile
View Bullboard History
Comment by
Timorron
on Jun 01, 2015 2:55pm
RE:An interesting open..
Someone bought the stock at 0.25$ today. I wonder if it is a cross trade or the reflect of this thin selling side.
Fintech Select LTD. Publishes Results for Fiscal Year 2023
posted May 01, 2024 9:00am by
Fintech Select Ltd.
-
|
Under the leadership of Fintech Select's management, the Company achieved a significant milestone in revenue generation, reaching $3,822,182 for fiscal year 2023, compared to $2,587,867 in 2022. Management is confident this 47% increase on a year-over-year basis ...read more
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on Jun 01, 2015 9:49am
An interesting open..
DIAGNOCURE INC (CA: CUR) Real-time Last: 0.195 Change:
...more
(0)
•••
oceanblvd
X
View Profile
View Bullboard History
Post by
oceanblvd
on May 29, 2015 2:03pm
pca3
for those of you who have not sold your stock in cur do you realize this could be a $3 to $4 stock if hologic were marketing this. as it is both the cleveland clinic and mayo clinic both use
...more
(0)
•••
Timorron
X
View Profile
View Bullboard History
Comment by
Timorron
on May 19, 2015 2:13pm
RE:Abstract: PCP Risk Score; AUA May 15h, New Orleans
wow
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on May 18, 2015 6:29pm
Abstract: PCP Risk Score; AUA May 15h, New Orleans
Abstract: MP1-03 Introduction and Objectives While screening for prostate cancer (PCa) using the prostate-specific antigen (PSA) serum level has been shown to reduce cancer mortality, it also led to
...more
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Comment by
Dibah42
on May 09, 2015 2:15pm
RE:my opinion...
Well Kondero that victory seems, at least to this old coot, a trifle pyrrhic. The much vaunted R&D team has been disbanded and there is no evidence of research emanating from the lab. Most of the
...more
(0)
•••
Kondero
X
View Profile
View Bullboard History
Post by
Kondero
on May 09, 2015 10:58am
my opinion...
The last general meeting of shareholders has been a victory for Fradet; at last we know that Bordeleau is still on board... A majority of shareholders understood that the strength of Diagnocure is in
...more
(0)
•••
oceanblvd
X
View Profile
View Bullboard History
Comment by
oceanblvd
on May 06, 2015 3:34pm
RE:RE:Merger and Prefered Share Right
anyone who has to be told this schould not be in the stock. the problem with the stockholders is the feel in a takeover or merger what could they get when the stock is trading down here for pennies
...more
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Comment by
Dibah42
on May 04, 2015 2:36pm
RE:Merger and Prefered Share Right
The preferreds held by HOLX/GPRO are non-voting. No vote, no veto.
(5)
•••
RetailRube
X
View Profile
View Bullboard History
Post by
RetailRube
on May 04, 2015 11:34am
Merger and Prefered Share Right
Does the owner of the Pref Shares get to veto a merger which involves a share swap? In a cash takeover, the answer would be easy: Buyer spends $5m for the pref shares. No
...more
(22)
•••
modulex
X
View Profile
View Bullboard History
Post by
modulex
on May 01, 2015 5:18pm
ANDY SHELDON - PROFILE
Mr. Sheldon has been President and Chief Executive Officer of Medicago since August 2003. He has thirty years of experience in the pharmaceutical industry, and was named CEO of the Year by the Vaccine
...more
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Comment by
Dibah42
on Apr 30, 2015 8:37pm
RE:HOPE TO SEE CUR MOVING UP $1.00 +
Where is the evidence on Andy Sheldon's activities?
(22)
•••
modulex
X
View Profile
View Bullboard History
Post by
modulex
on Apr 30, 2015 7:57pm
HOPE TO SEE CUR MOVING UP $1.00 +
Diagnocure 's director Andrew Sheldon is likely playing a key role in having talks going forward with potential partners/suitors that will recognize value in the company. I hope it will not
...more
(0)
•••
Keedan
X
View Profile
View Bullboard History
Comment by
Keedan
on Apr 30, 2015 10:50am
RE:RE:RE:RE:RE:Merger possibilities
No, I am not.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition